Share your videos with the world

Sign Up | Log In | Help  

Search // cologuard
Results 1-1 of 1 for ' cologuard ' (0 seconds)
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home. To view the Multimedia News Release, go to
Categories // People and Blog  Business 
Added: 1317 days ago by MultiVuVideos
Runtime: 2m14s | Views: 288 | Comments: 0
Not yet rated



Page 1 of 1  |  Go to page   

About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 All rights reserved.